Morgan Stanley’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

Morgan Stanley’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-27,984	Closed	-$176K	–	5523
2013 Q2	$176K	Buy	+27,984	New	+$168K	﹤0.01%	4900

Other funds holding PBTH

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Morgan Stanley's PBTH Position: Q3 2013 in Review

Morgan Stanley sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 27,984 shares — an estimated $176K sold.

Morgan Stanley first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $176K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

Morgan Stanley reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
Morgan Stanley sold 27,984 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $176K.
Morgan Stanley first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
Morgan Stanley's PROLOR Biotech, Inc. Common Stock position peaked at $176K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on Morgan Stanley's 13F filing for Q3 2013, filed 13 Nov 2013.